Slovakia’s approved Amendment to Act no. 595/2003 Coll. on Income Tax (ITA) and approved Amendment to Act no. 222/2004 Coll. on Value Added Tax (VATA), bring significant changes to the tax laws, effective 1 January 2018, which may affect pharmaceutical companies. The most relevant of these changes are:
The State Institute for Drug Control in Czech Republic (SUKL) has published the information with regard to reporting of registration holder pursuant to Section 33, paragraph 2 of Act on Pharmaceuticals. It draws the attention to the obligations set out in Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (hereinafter…
The Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM) has welcomed the fact that the size of the pharmaceutical budget (the price subsidy for medicinal products available in pharmacies) will increase according to the draft budget for 2018. According to the draft legislation, the size of the pharma budget will be 337.4 billion forints ($1.22 billion),…
In 2017 the pharmaceutical market in Poland posted a 5.4 percent growth. The industry continues to demonstrate value growth with a total market estimated at EUR9bn. The surge in demand for over the counter medicinal products largely contributed to the sector growth. It is access to innovative prescription pharmaceutical products and improvement of drug reimbursement…
The European Medicines Agency (EMA) on Wednesday said it expects fees paid by drugmakers for pharmacovigilance applications to rise by 1.4% in mid-January 2018. Pharmacovigilance fees in in the EU are set by Regulation (EU) No 658/2014, which includes provisions for the European Commission to adjust the fees to keep up with the rate of…
On December 8, 2017 in Almaty in a solemn atmosphere, the ceremony of signing the Code of Ethics of the Association of International Pharmaceutical Manufacturers of the Republic of Kazakhstan was held. The signing was attended by the chief specialist of the Department of the Pharmacy Committee of the Ministry of Health of the Republic…
According to industry experts, the medical device market in Croatia was valued at $268 million in 2016. The market demonstrates solid growth and is expected to reach $294 million in 2017. The largest product categories are consumables (24% of the total market) followed by patient aids, dental products and orthopaedics. Imports account for around 90%…
The pharmaceutical industry has been one of the top economy sectors in Croatia for years. The Croatian pharmaceutical industry is one of the most important and strongest sectors in Croatia, and pharmaceutical companies and medicine wholesale trading companies are near the top of the charts of the largest Croatian enterprises when it comes to revenues.…
Pfizer’s recent decision to open a European logistics hub in Romania is a strong evidence of a long term commitment that international pharmaceutical manufacturers are increasingly demonstrating towards the Romanian market and indeed a broader Eastern European region. Romania continuously improves its scoring in the context of trained workforce, pharmaceutical supply chain efficiency, compliance standards…
Importers of medicines are trying to restore their positions in the Kazakhstan market, in January-August this year, Kazakhstan imported 16.6 thousand tons of medicines, or 32.9% more than in the same period in 2016. Thus, the volume of imports of medicines exceeded the levels not only in 2016 but also in 2015 (14.6 thousand tons…